• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
COV
Click for more information
0.00% 37.0¢

CLEO DIAGNOSTICS LTD - Announcements

Market Cap $32.64M  ! watchlist Created with Sketch. Add to my watchlist

Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal... Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal activities involve the development and patent of a blood test for the detection of ovarian cancer. It focuses on bringing to market a blood test for the early diagnosis of ovarian cancer based on the novel CXCL10 biomarker, which is produced early and at high levels by ovarian cancers but is largely absent in non-malignant disease. It is advancing the availability of its blood test, under a modular execution strategy, which is designed to address all ovarian cancer detection markets with specific tests, including surgical triage, recurrence, high risk, and early-stage screening. It has developed a three-phased product development strategy that delivers three related tests for ovarian cancer detection: Triage Test, Recurrence Test, and Screening Test. Triage Test is a pre-surgical test to determine the likelihood that a pre-surgical ovarian mass in a patient not yet referred to an oncologist, is malignant.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
COVRemoval from Official List (cob 24 02 2010)23/02/10
COV +Amended ASX Circular - Scheme of Arrangement12/02/10
COVSuspension from official quotationPRICE SENSITIVE11/02/10
COV +Court Order Lodged with ASIC10/02/10
COV +Federal Court Approves Scheme09/02/10
COV +ASX Circular - Scheme of Arrangement08/02/10
COV +Results of General Meeting to Approve Scheme28/01/10
COVQuarterly Report and Appendix 5BPRICE SENSITIVE25/01/10
COV +Scheme Booklet and Notice of Scheme Meeting24/12/09
COV +Update on Merger with Tianshan Goldfields Limited22/12/09
COV +Corvette Issues Second Convertible Note18/12/09
COV +Corvette Issues Second Convertible NotePRICE SENSITIVE18/12/09
COVPresentation to Gold Investor Forum, Sydney, 7 Dec 0907/12/09
COV +$60M Merger Agreement Executed27/11/09
COV +Tianshan and Corvette sign Merger Implementation Agreement27/11/09
COVResults of Annual General Meeting26/11/09
COVAGM Presentation24/11/09
COVAppendix 3B - Issue of Options20/11/09
COVMerger Agreement17/11/09
COV +Tianshan and Corvette Agree to AU$60M MergerPRICE SENSITIVE17/11/09
COVDiamond Core DrillingPRICE SENSITIVE03/11/09
COVAnnual Report to Shareholders02/11/09
COVActivities Report and Appendix 5BPRICE SENSITIVE30/10/09
COVNotice of Annual General Meeting23/10/09
COVTianshan issues A$1M Convertible Note to Corvette Resources22/10/09
COVConvertible Note IssuedPRICE SENSITIVE22/10/09
COVHigh Grade Gold DiscoveryPRICE SENSITIVE20/10/09
COVAppointment of Company Secretary02/10/09
COVAnnual Report to shareholders29/09/09
COVChange of Address and Contact Details24/09/09
COVInvestor Presentation23/09/09
COVTwo New Gold Zones at CorvettePRICE SENSITIVE31/08/09
COVTarget Statement21/08/09
COVQuarterly Activities ReportPRICE SENSITIVE30/07/09
COVSignificant Intersections of High Grade Gold at StingrayPRICE SENSITIVE28/07/09
COVAwarded EIS Drilling Grant FundingPRICE SENSITIVE29/06/09
COVHigh Grade Gold Intersection from RC Drilling at CorvettePRICE SENSITIVE25/06/09
COVCorvette and CSIRO commence Research ProgrammePRICE SENSITIVE19/05/09
COVPresentation to Gold Investor Forum13/05/09
COVReplacement Appendix 3Y Change in Directors Interests12/05/09
COVAppendix 3B Release from Escrow12/05/09
COVGrant of Options to Non-Executive Directors05/05/09
COVChange of Director's Interest Notice01/05/09
COVQuarterly Activities and Cashflow ReportsPRICE SENSITIVE22/04/09
COVChange of Director's Interest Notice14/04/09
COVBroker Presentation (Amended)23/03/09
COVBroker Presentation23/03/09
COVChange of Director's Interest Notice20/03/09
COVCorvette Intersects 15g/t goldPRICE SENSITIVE19/03/09
COVHalf Yearly AccountsPRICE SENSITIVE11/03/09
COVRC Drilling Intersects Gold along 8 km StructurePRICE SENSITIVE05/03/09
COVInitial Director's Interest Notice27/02/09
COVInitial Director's Interest Notice27/02/09
COVFinal Director's Interest Notice27/02/09
COVFinal Director's Interest Notice27/02/09
COVDirector Appointment/Resignation26/02/09
COVAircore Drilling Enhances Gold ZonePRICE SENSITIVE11/02/09
COVQuarterly Activities ReportPRICE SENSITIVE22/01/09
COVResponse to ASX Query - Change in Directors Interest Notices19/01/09
COVChange of Director's Interest Notice16/01/09
COVChange of Director's Interest Notice16/01/09
COVChange of Director's Interest Notice16/01/09
COVAppendix 3B14/01/09
COVDrilling Programme CompletedPRICE SENSITIVE19/12/08
COVFinal Director's Interest Notice28/11/08
COVResignation of Non Executive Director28/11/08
COV +Substanial Shareholder CopperCo Limited27/11/08
COVRemoval from Official List (cob 24 02 2010)
23/02/10
COV +Amended ASX Circular - Scheme of Arrangement
12/02/10
COVSuspension from official quotation
11/02/10PRICE SENSITIVE
COV +Court Order Lodged with ASIC
10/02/10
COV +Federal Court Approves Scheme
09/02/10
COV +ASX Circular - Scheme of Arrangement
08/02/10
COV +Results of General Meeting to Approve Scheme
28/01/10
COVQuarterly Report and Appendix 5B
25/01/10PRICE SENSITIVE
COV +Scheme Booklet and Notice of Scheme Meeting
24/12/09
COV +Update on Merger with Tianshan Goldfields Limited
22/12/09
COV +Corvette Issues Second Convertible Note
18/12/09
COV +Corvette Issues Second Convertible Note
18/12/09PRICE SENSITIVE
COVPresentation to Gold Investor Forum, Sydney, 7 Dec 09
07/12/09
COV +$60M Merger Agreement Executed
27/11/09
COV +Tianshan and Corvette sign Merger Implementation Agreement
27/11/09
COVResults of Annual General Meeting
26/11/09
COVAGM Presentation
24/11/09
COVAppendix 3B - Issue of Options
20/11/09
COVMerger Agreement
17/11/09
COV +Tianshan and Corvette Agree to AU$60M Merger
17/11/09PRICE SENSITIVE
COVDiamond Core Drilling
03/11/09PRICE SENSITIVE
COVAnnual Report to Shareholders
02/11/09
COVActivities Report and Appendix 5B
30/10/09PRICE SENSITIVE
COVNotice of Annual General Meeting
23/10/09
COVTianshan issues A$1M Convertible Note to Corvette Resources
22/10/09
COVConvertible Note Issued
22/10/09PRICE SENSITIVE
COVHigh Grade Gold Discovery
20/10/09PRICE SENSITIVE
COVAppointment of Company Secretary
02/10/09
COVAnnual Report to shareholders
29/09/09
COVChange of Address and Contact Details
24/09/09
COVInvestor Presentation
23/09/09
COVTwo New Gold Zones at Corvette
31/08/09PRICE SENSITIVE
COVTarget Statement
21/08/09
COVQuarterly Activities Report
30/07/09PRICE SENSITIVE
COVSignificant Intersections of High Grade Gold at Stingray
28/07/09PRICE SENSITIVE
COVAwarded EIS Drilling Grant Funding
29/06/09PRICE SENSITIVE
COVHigh Grade Gold Intersection from RC Drilling at Corvette
25/06/09PRICE SENSITIVE
COVCorvette and CSIRO commence Research Programme
19/05/09PRICE SENSITIVE
COVPresentation to Gold Investor Forum
13/05/09
COVReplacement Appendix 3Y Change in Directors Interests
12/05/09
COVAppendix 3B Release from Escrow
12/05/09
COVGrant of Options to Non-Executive Directors
05/05/09
COVChange of Director's Interest Notice
01/05/09
COVQuarterly Activities and Cashflow Reports
22/04/09PRICE SENSITIVE
COVChange of Director's Interest Notice
14/04/09
COVBroker Presentation (Amended)
23/03/09
COVBroker Presentation
23/03/09
COVChange of Director's Interest Notice
20/03/09
COVCorvette Intersects 15g/t gold
19/03/09PRICE SENSITIVE
COVHalf Yearly Accounts
11/03/09PRICE SENSITIVE
COVRC Drilling Intersects Gold along 8 km Structure
05/03/09PRICE SENSITIVE
COVInitial Director's Interest Notice
27/02/09
COVInitial Director's Interest Notice
27/02/09
COVFinal Director's Interest Notice
27/02/09
COVFinal Director's Interest Notice
27/02/09
COVDirector Appointment/Resignation
26/02/09
COVAircore Drilling Enhances Gold Zone
11/02/09PRICE SENSITIVE
COVQuarterly Activities Report
22/01/09PRICE SENSITIVE
COVResponse to ASX Query - Change in Directors Interest Notices
19/01/09
COVChange of Director's Interest Notice
16/01/09
COVChange of Director's Interest Notice
16/01/09
COVChange of Director's Interest Notice
16/01/09
COVAppendix 3B
14/01/09
COVDrilling Programme Completed
19/12/08PRICE SENSITIVE
COVFinal Director's Interest Notice
28/11/08
COVResignation of Non Executive Director
28/11/08
COV +Substanial Shareholder CopperCo Limited
27/11/08
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
37.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $32.64M
Open High Low Value Volume
37.0¢ 38.0¢ 37.0¢ $21.48K 58.04K

Buyers (Bids)

No. Vol. Price($)
2 21917 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 6091 1
Last trade - 13.32pm 15/11/2024 (20 minute delay) ?
Last
37.0¢ 		  Change
0.000 ( 1.37 %)
Open High Low Volume
38.0¢ 38.0¢ 37.0¢ 26563
Last updated 12.16pm 15/11/2024 ?
COV (ASX) Chart

Top Stories

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.